Clinical Trial Update: A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different doses of Avenciguat (BI 685509) for effects on kidney function in chronic kidney disease has been completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Avenciguat

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-09-04